StockData
Shuttle Pharmaceuticals Holdings, Inc. logo

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock

SHPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Sep 24, 2026Score 5/30
$4.30+0.06 (+1.42%)

Close on Nov 17, 2026Market cap $4.31MP/E –Yield –

Shuttle Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Shuttle Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$6.58M. For fiscal 2025 it was -$9.48M. The highest annual figure on record is -$300.34K in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$9.48M–
FY2024Dec 31, 2024-$7.33M–
FY2023Dec 31, 2023-$5.58M–
FY2022Dec 31, 2022-$2.67M–
FY2021Dec 31, 2021-$300.34K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$567.64K–
Q1 FY2026Mar 31, 2026-$2.42M–
Q4 FY2025Dec 31, 2025-$973.01K–
Q3 FY2025Sep 30, 2025-$2.63M–
Q2 FY2025Jun 30, 2025-$3.36M–
Q1 FY2025Mar 31, 2025-$2.53M–
Q4 FY2024Dec 31, 2024-$2.69M–
Q3 FY2024Sep 30, 2024-$2.00M–
Q2 FY2024Jun 30, 2024-$1.40M–
Q1 FY2024Mar 31, 2024-$1.24M–
Q4 FY2023Dec 31, 2023-$1.06M–
Q3 FY2023Sep 30, 2023-$1.53M–
Q2 FY2023Jun 30, 2023-$1.65M–
Q1 FY2023Mar 31, 2023-$1.34M–
Q4 FY2022Dec 31, 2022-$635.82K–
Q3 FY2022Sep 30, 2022-$1.05M–
Q2 FY2022Jun 30, 2022-$355.42K–
Q1 FY2022Mar 31, 2022-$624.61K–
Q4 FY2021Dec 31, 2021-$135.15K–

More Shuttle Pharmaceuticals figures

See a number that looks wrong?